| Ms Stephanie Strawbridge Governor, RPH | |
|
2011 Springhill Ave, Mobile, AL 36607-3326 | |
| (251) 479-1236 | |
| Not Available |
| Full Name | Ms Stephanie Strawbridge Governor |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 2011 Springhill Ave, Mobile, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487943379 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 11577 (Alabama) | Primary |
| 183500000X | Pharmacist | E7921 (Mississippi) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Stephanie Strawbridge Governor, RPH 2011 Springhill Ave, Mobile, AL 36607-3326 Ph: (251) 479-1236 | Ms Stephanie Strawbridge Governor, RPH 2011 Springhill Ave, Mobile, AL 36607-3326 Ph: (251) 479-1236 |
News Archive
Forty years ago, children born with sickle cell disease (SCD) were not expected to live past their teenage years. Today, medical advances are allowing children to live well into adulthood, raising concerns over who is going to care for these patients as adults. However, programs are underway to address these concerns, as reported in the March/April edition of Journal of Pediatric Oncology Nursing, published by the Association of Pediatric Hematology/Oncology Nurses (APHON).
Boehringer Ingelheim will present a pooled analysis of new data from the Phase 3 UniTinA-asthma® program at the European Respiratory Society (ERS) Annual Congress 2013 in Barcelona. The data from the individual MezzoTinA-asthma® Phase 3 studies (NCT01340209 and NCT00565266), from which the pooled data are derived, show the addition of tiotropium delivered via the Respimat® inhaler to medium-dose maintenance inhaled corticosteroid (ICS) therapy (defined as 400-800 µg budesonide/day or equivalent) improved lung function and provided sustained bronchodilation over 24 hours in patients with moderate asthma and airflow limitation. Tiotropium is being investigated to determine the medicine's efficacy in treating asthma patients and is not currently approved for this indication.
There is now new evidence that animals in fact do an impressive job of keeping up in the ongoing evolutionary arms race between viruses and their hosts.
The U.S. Securities and Exchange Commission is going after some former WellCare Health Plans executives in federal civil court regarding their alleged actions concerning WellCare's managed-care contracts for behavioral health in the state of Florida. In 2010, WellCare agreed to pay about $334 million to settle legal actions with various entities related to an alleged $40 million, five-year pattern of fraud in those contracts without admitting or denying any wrongdoing.
› Verified 6 days ago
Dr. Wilfred Arcard Brown, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3948 Airport Blvd, Mobile, AL 36608 Phone: 251-345-3394 | |
Chidiya Ohiagu, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1303 Dr Martin L King Jr Ave, Mobile, AL 36603 Phone: 251-432-4117 | |
Darren P Billiot, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6575 Airport Blvd, Mobile, AL 36608 Phone: 251-370-9848 | |
Eric Donaldson Reeves, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4628 Airport Blvd, Mobile, AL 36608 Phone: 251-341-5749 | |
Mr. Chuck P Whisonant, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1504 Spring Hill Ave, Mobile, AL 36604 Phone: 251-219-3754 | |
Ms. Angela F. Amos, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 251 N Bayou St, Mobile, AL 36603 Phone: 251-690-8817 | |
Dr. Raymond Lorenz, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2400 Gordon Smith Dr, Mobile, AL 36617 Phone: 251-450-1388 |